Envisioned commercial opportunity for boutique consulting firm specializing in forecasting and asset valuation. Marketed company, grew business, developed strategic partnerships, and created core capabilities.

Enabled corporate decision making by synthesizing advanced analytics, market insights, competitive intelligence, and HTA analyses into a robust long range plan. Partnered with senior leaders across the organization to ensure alignment on financial commitments.
• Guided risk and opportunity assessments, analytics, insights generation, and launch KPIs.
• Framed business questions and delivered innovative solutions to value assets for innovative business model.
• Invited to serve as member of the PD1 Strategy Extended Team and Portfolio Decision Forum.

Architected the scale up of Keytruda forecasting team and capabilities from pre-launch to over $17B, encompassing over 30 tumors and spanning 6 assets across solid tumors, hematology, and rare diseases. Framed key business questions and delivered innovative methodologies to value assets given market uncertainties. Oversaw the implementation of Monte Carlo analysis to guide the level of risk integrated in the annual budget.
• De-risked oncology portfolio by $500MM using real world evidence and advanced analytics.
• Gained senior sponsorship to invest in a web based forecast platform capable of transforming forecasts from a tactical planning tool to a strategic planning platform. Led design across IT, marketing, and country teams.
• Expanded team mission to identify opportunities to increase top line sales using root cause analysis vs planned objectives. Established a goal of contributing to an additional 5% of top line sales growth.
• Successfully influenced Chinese investment level

Engaged global medical and scientific leaders to gain deeper insights into potentially new standards of care. Partnered with marketing and medical teams to ensure strategic and scientific questions were sufficiently answered during advisory boards.
• Formed global advisory boards by partnering with marketing, advanced analytics teams and medical affairs to identify and recruit scientific leaders.
• Gained insights from advisors on clinical development plans and tactics for Emend and Zolinza by gaining internal consensus on decisions needed, guiding content development, designing thought provoking questions, and summarizing and interpreting feedback.
● Project Manager, Customer Insights Designed and managed qualitative and quantitative market research to inform strategic choices for the diabetes, atherosclerosis, and hypertension marketing teams.
• Guided strategic choices for the Cordaptive marketing team. Identified leverage points and priority customer segments via the Buying Pro